← Human Trials & Peer-Reviewed Studies

Interrelations between growth hormone and sex hormones: physiology and therapeutic consequences.

Plain-language guide to PMID 1295806 (1992): review of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

Key Facts

PMID
1295806
Journal
Hormone research
Year
1992
Study type
Review
Authors
Zachmann M
DOI
10.1159/000182562

What This Paper Covers, in Plain Language

What It Covers

The paper reports a study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over), published as a review.

Animal experiments, analysis of growth hormone (GH) secretion in the human, studies on the synergistic metabolic effects between GH and sex hormones using the stable isotope 15N, and long-term growth evaluation of patients with GH and gonadotrophin deficiency treated with testosterone and hGH show that biologically important interrelations exist between GH and sex hormones.

They are operative not only at the pituitary and gonadal levels but also in peripheral tissues, where sex hormones modify the metabolic and growth-promoting effects of GH.

Who the Included Studies Covered

PubMed tags the participants as both men and women.

What Was Measured

Animal experiments, analysis of growth hormone (GH) secretion in the human, studies on the synergistic metabolic effects between GH and sex hormones using the stable isotope 15N, and long-term growth evaluation of patients with GH and gonadotrophin deficiency treated with testosterone and hGH show that biologically important interrelations exist between GH and sex hormones.

They are operative not only at the pituitary and gonadal levels but also in peripheral tissues, where sex hormones modify the metabolic and growth-promoting effects of GH.

PubMed files the paper under topics including Androgens, Drug Synergism, Estrogens, Gonadal Steroid Hormones, Growth, Growth Hormone and Sexual Maturation.

What This Means in Plain Language

This is a review of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

The publication is from 1992 (Hormone research), a journal based in Switzerland.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.

Our Notes on the Compound

Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.